Hamden, CT, United States of America

Erkut Bahceci

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cell Transfection by Erkut Bahceci

Introduction

Erkut Bahceci is a notable inventor based in Hamden, CT (US), recognized for his contributions to the field of molecular biology and cell therapy. With a focus on innovative methods for cell modification, he has been instrumental in advancing techniques that have significant implications for treating various diseases.

Latest Patents

Bahceci holds 3 patents, with his latest inventions centered around the preparation of cells through transient transfection. His patents detail compositions and methods for making cells using RNA, which can induce molecular, biological, physiological, or histological changes in the cells. Notably, these methods can be applied to treat or inhibit disorders such as cancer by administering effective amounts of RNA or modified cells to patients. His work also explores the potential of modifying immune cells and stem cells to enhance their therapeutic capabilities.

Career Highlights

Erkut Bahceci is affiliated with Yale University, where he continues to push the boundaries of research in cell biology. His innovative approaches have garnered attention in the scientific community, contributing to the development of new therapeutic strategies.

Collaborations

Bahceci has collaborated with esteemed colleagues, including Peter M. Rabinovich and Sherman M. Weissman, to further his research endeavors. Their combined expertise has enriched the projects they have undertaken together.

Conclusion

Erkut Bahceci's work in cell transfection and modification represents a significant advancement in the field of biomedical research. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients with various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…